Skip to main content
Gulf Pharmaceutical Industries logo

Gulf Pharmaceutical Industries — Investor Relations & Filings

Ticker · JULPHAR ISIN · AEG000201018 Abu Dhabi Securities Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2021-04-18 Regulatory Filings
Country AE United Arab Emirates
Listing Abu Dhabi Securities Exchange JULPHAR

About Gulf Pharmaceutical Industries

https://www.Julphar.net

Gulf Pharmaceutical Industries (Julphar) is a prominent pharmaceutical manufacturer and distributor. The company specializes in producing a diverse portfolio of medicines, vaccines, and consumer healthcare products, addressing a broad spectrum of health conditions. Julphar is recognized as one of the largest generic pharmaceutical manufacturers in the Middle East and North Africa, and a leading global producer of insulin. Utilizing internationally accredited, state-of-the-art facilities, it manufactures over one million medicine boxes daily, distributing products to more than 40 countries. The company's operations emphasize high quality and safety standards in its comprehensive manufacturing capabilities.

Recent filings

Filing Released Lang Actions
شركة الخليج للصناعات الدوائية نتائج اجتماع جمعية عمومية 18/04/2021 الساعة 13:00
Regulatory Filings
2021-04-18 Arabic
Gulf Pharmaceutical Industries AGM Results held on 18/04/2021 at 13:00
Regulatory Filings
2021-04-18 English
شركة الخليج للصناعات الدوائية الافصاح
Notice of Dividend Amount Classification · 90% confidence The document text is in Arabic and appears to be a short announcement related to shareholder matters, specifically mentioning cash dividends and dates around March 2015 and 2021. The text is only 2705 characters long, which is quite short and does not contain detailed financial statements or comprehensive financial data. It also references a website link for more information, suggesting it is an announcement rather than a full report. There is no indication of detailed financial results, management discussion, or audit information. The content aligns with a Notice of Dividend Amount, as it discusses cash dividends and shareholder receipt dates. Therefore, the document is best classified as a Notice of Dividend Amount (DIV).
2021-04-04 Arabic
Gulf Pharmaceutical Industries Announcements
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from Gulf Pharmaceutical Industries (Julphar) regarding outstanding cash dividends owed to shareholders before March 1, 2015. It provides instructions for shareholders to claim their unpaid dividends and details the required documentation. The document does not contain financial statements, management discussion, or detailed financial data. It is primarily an announcement about dividend payments and the process for claiming them, not a report or detailed financial filing. Therefore, it fits the category of Notice of Dividend Amount (DIV), as it relates to dividend payment information and shareholder instructions.
2021-04-04 English
شركة الخليج للصناعات الدوائية تقرير الحوكمة عن الفترة المنتهية في 31 ديسمبر,2020
Regulatory Filings
2021-03-29 Arabic
Gulf Pharmaceutical Industries Corporate Governance Report for the year December 31,2020
Regulatory Filings
2021-03-29 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.